Immunotherapy in head and neck cancer: aiming at EXTREME precision

BACKGROUND: Locoregionally advanced, recurrent, and metastatic squamous cell carcinomas of the head and neck (SCCHN) remain difficult to treat disease entities, in which systemic treatment often forms an integral part of their management. Immunotherapy is based on functional restoration of the host...

Descripción completa

Detalles Bibliográficos
Autores principales: Szturz, Petr, Vermorken, Jan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455211/
https://www.ncbi.nlm.nih.gov/pubmed/28571578
http://dx.doi.org/10.1186/s12916-017-0879-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455211/
https://www.ncbi.nlm.nih.gov/pubmed/28571578
http://dx.doi.org/10.1186/s12916-017-0879-4

Ejemplares similares